Bioactive molecule optimized for biofilm reduction related to childhood caries

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2(2), 95–108 (2004).
  Medline CASGoogle Scholar
• 2. He J, Kim D, Zhou X et al. RNA-seq reveals enhanced sugar metabolism in Streptococcus mutans co-cultured with Candida albicans within mixed-species biofilms. Front. Microbiol. 8, 1036 (2017).
  MedlineGoogle Scholar
• 3. Bachtiar EW, Bachtiar BM. Relationship between Candida albicans and Streptococcus mutans in early childhood caries, evaluated by quantitative PCR. Version 2 F1000Res. 7, 1645 (2018). •• Demonstrates the positive correlation of Candida albicans with cariogenic traits of Streptococcus mutans in early childhood caries-related biofilm of young children.
  Medline CASGoogle Scholar
• 4. Qiu R, Li W, Lin Y, Yu D, Zhao W. Genotypic diversity and cariogenicity of Candida albicans from children with early childhood caries and caries-free children. BMC Oral Health 15, 144 (2015).
  MedlineGoogle Scholar
• 5. Carvalho FG, Silva DS, Hebling J, Spolidorio LC, Spolidorio DM. Presence of mutans streptococci and Candida spp. in dental plaque/dentine of carious teeth and early childhood caries. Arch. Oral Biol. 51(11), 1024–1028 (2006). • Demonstrates a significant association between the presence of C. albicans and early childhood caries.
  MedlineGoogle Scholar
• 6. Klinke T, Urban M, Lück C, Hannig C, Kuhn M, Krämer N. Changes in Candida spp., mutans streptococci and lactobacilli following treatment of early childhood caries: a 1-year follow-up. Caries Res. 48(1), 24–31 (2014).
  Medline CASGoogle Scholar
• 7. Joyner PM, Liu J, Zhang Z, Merritt J, Qi F, Cichewicz RH. Mutanobactin A from the human oral pathogen Streptococcus mutans is a cross-kingdom regulator of the yeast-mycelium transition. Org. Biomol. Chem. 8(24), 5486–5489 (2010).
  Medline CASGoogle Scholar
• 8. Gomes MN, Muratov EN, Pereira M et al. Chalcone derivatives: promising starting points for drug design. Molecules 22(8), 1–25 (2017).
  Google Scholar
• 9. Nowakowska Z. Structural characterization and differentiation of isomeric omega-bromoalkoxy derivatives of (E)-chalcone by means of mass spectrometry. Eur. J. Mass Spectrom. 14(1), 37–47 (2008).
  Medline CASGoogle Scholar
• 10. Shakhatreh MA, Al-Smadi ML, Khabour OF, Shuaibu FA, Hussein EI, Alzoubi KH. Study of the antibacterial and antifungal activities of synthetic benzyl bromides, ketones, and corresponding chalcone derivatives. Drug Des. Devel. Ther. 8, 3653–3660 (2016).
  Google Scholar
• 11. Wang YH, Dong HH, Zhao F et al. The synthesis and synergistic antifungal effects of chalcones against drug resistant Candida albicans. Bioorg. Med. Chem. Lett. 26(13), 3098–3102 (2016). • Demonstrates the antifungal action of chalcones.
  Medline CASGoogle Scholar
• 12. Bukhari SN, Tajuddin Y, Benedict VJ et al. Synthesis and evaluation of chalcone derivatives as inhibitors of neutrophils' chemotaxis, phagocytosis and production of reactive oxygen species. Chem. Biol. Drug Des. 83(2), 198–206 (2015).
  Google Scholar
• 13. Molinspiration Cheminformatics. www.molinspiration.com
  Google Scholar
• 14. PreADMET. https://preadmet.bmdrc.kr
  Google Scholar
• 15. CLSI. Reference Method for Broth Dilutionantifungal Susceptibility Testing of Yeasts; Approved Standard (3rd Edition). CLSI document M27-A3 (ISBN-1-56238-666-2). Clinical and Laboratory Standards Institute, PA, USA (2008).
  Google Scholar
• 16. CLSI. Reference Method for Broth Dilutionantifungal Susceptibility Testing of Bacterial; Approved Standard (9th Edition). CLSI document M07-A9 (ISBN 1-56238-783-9). Clinical and Laboratory Standards Institute, PA, USA (2012).
  Google Scholar
• 17. Sardi JCO, Polaquini CR, Freires IA et al. Antibacterial activity of diacetylcurcumin against Staphylococcus aureus results in decreased biofilm and cellular adhesion. J. Med. Microbiol. 66(6), 816–824 (2017).
  Medline CASGoogle Scholar
• 18. Sardi JC, Freires IA, Lazarini JG, Infante J, de Alencar SM, Rosalen PL. Unexplored endemic fruit species from Brazil: antibiofilm properties, insights into mode of action, and systemic toxicity of four Eugenia spp. Microb. Pathog. 105, 280–287 (2017).
  Medline CASGoogle Scholar
• 19. Dos Santos Ramos MA, de Toledo LG, Calixto GM et al. Syngonanthus nitens Bong. (Rhul.)-loaded nanostructured system for vulvovaginal candidiasis treatment. Int. J. Mol. Sci. 17(8), pii:E1368 (2016).
  Google Scholar
• 20. Saito ST, Trentin Dda S, Macedo AJ et al. 2012 Bioguided fractionation shows Cassia alata extract to inhibit Staphylococcus epidermidis and Pseudomonas aeruginosa growth and biofilm formation. Evid. Based Complement. Alternat. Med. 2012, 867103 (2012).
  MedlineGoogle Scholar
• 21. Sardi JC, Duque C, Mariano FS, Marques MR, Höfling JF, Gonçalves RB. Adhesion and invasion of Candida albicans from periodontal pockets of patients with chronic periodontitis and diabetes to gingival human fibroblasts. Med. Mycol. 50(1), 43–49 (2012).
  Medline CASGoogle Scholar
• 22. André CB, Rosalen PL, Galvão LCC et al. Modulation of Streptococcus mutans virulence by dental adhesives containing anti-caries agents. Dent. Mater. 33(10), 1084–1092 (2017).
  Medline CASGoogle Scholar
• 23. Lazarini JG, Sardi JCO, Franchin M et al. Bioprospection of Eugenia brasiliensis, a Brazilian native fruit, as a source of anti-inflammatory and antibiofilm compounds. Biomed. Pharmacother. 102, 132–139 (2018).
  Medline CASGoogle Scholar
• 24. Megaw J, Thompson TP, Lafferty RA, Gilmore BF. Galleria mellonella as a novel in vivo model for assessment of the toxicity of 1-alkyl-3-methylimidazolium chloride ionic liquids. Chemosphere 139, 197–201 (2015). •• First to demonstrate toxicity in the alternative model Galleria mellonella.
  Medline CASGoogle Scholar
• 25. Aparecida Procópio Gomes L, Alves Figueiredo LM, Luiza do Rosário Palma A et al. Punica granatum L. (pomegranate) extract: in vivo study of antimicrobial activity against Porphyromonas gingivalis in Galleria mellonella model. Sci. World J. 2016, 8626987 (2016).
  Google Scholar
• 26. Willems HM, Xu Z, Peters BM. Polymicrobial biofilm studies: from basic science to biofilm control. Curr. Oral Health Rep. 3(1), 36–44 (2016).
  MedlineGoogle Scholar
• 27. Barua DR, Basavanna JM, Varghese RK. Efficacy of neem extract and three antimicrobial agents incorporated into tissue conditioner in inhibiting the growth of C. albicans and S. mutans. J. Clin. Diagn. Res. 11(15), 97–101 (2017).
  Google Scholar
• 28. Hwang G, Liu Y, Kim D, Li Y, Krysan DJ, Koo H. Candida albicans mannans mediate Streptococcus mutans exoenzyme GtfB binding to modulate cross-kingdom biofilm development in vivo. PLoS Pathog. 13(6), e1006407 (2017).
  MedlineGoogle Scholar
• 29. Ellepola K, Liu Y, Cao T, Koo H, Seneviratne CJ. Bacterial GtfB augments Candida albicans accumulation in cross-kingdom biofilms. J. Dent. Res. 96(10), 1129–1135 (2017). • Demonstrates that a bacterial exoenzyme (GtfB) augments the C. albicans counterpart in mixed species biofilms through a BCR1-independent mechanism.
  Medline CASGoogle Scholar
• 30. Xiao J, Moon Y, Li L et al. Candida albicans carriage in children with severe early childhood caries (S-ECC) and maternal relatedness. PLoS ONE 11(10), e0164242 (2016).
  MedlineGoogle Scholar
• 31. Yang XQ, Zhang Q, Lu LY, Yang R, Liu Y, Zou J. Genotypic distribution of Candida albicans in dental biofilm of Chinese children associated with severe early childhood caries. Arch. Oral Biol. 57(8), 1048–1053 (2012).
  MedlineGoogle Scholar
• 32. Gross EL, Beall CJ, Kutsch SR, Firestone ND, Leys EJ, Griffen AL. Beyond Streptococcus mutans: dental caries onset linked to multiple species by 16S rRNA community analysis. PLoS ONE 7(10), e47722 (2012).
  Medline CASGoogle Scholar
• 33. Sardi Jde C, Pitangui Nde S, Rodríguez-Arellanes G, Taylor ML, Fusco-Almeida AM, Mendes-Giannini MJ. Highlights in pathogenic fungal biofilms. Rev. Iberoam. Micol. 31(1), 22–29 (2014).
  MedlineGoogle Scholar
• 34. Zhuang C, Zhang W, Sheng C, Zhang W, Xing C, Miao Z. Chalcone: a privileged structure in medicinal chemistry. Chem. Rev. 117(12), 7762–7810 (2017).
  Medline CASGoogle Scholar
• 35. Klopman G, Stefan LR, Saiakhov RD. ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans. Eur. J. Pharm. Sci. 17(4-5), 253–263 (2002).
  Medline CASGoogle Scholar
• 36. Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov. Today Technol. 1(4), 337–341 (2004).
  Medline CASGoogle Scholar
• 37. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45(12), 2615–2623 (2002).
  Medline CASGoogle Scholar
• 38. Papaioannou W, Vassilopoulos S, Vrotsos I, Margaritis V, Panis V. A comparison of a new alcohol-free 0.2% chlorhexidine oral rinse to an established 0.2% chlorhexidine rinse with alcohol for the control of dental plaque accumulation. Int. J. Dent. Hyg. 14(4), 272–277 (2016).
  Medline CASGoogle Scholar
• 39. Mesa-Arango AC, Forastiero A, Bernal-Martínez L, Cuenca-Estrella M, Mellado E, Zaragoza O. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. Med. Mycol. 51(5), 461–472 (2013). •• Demonstrates that G. mellonella is an alternative model for the study of host–pathogen interactions with Candida tropicalis and the in vivo efficacy of antifungals against this yeast.
  Medline CASGoogle Scholar